Black Diamond Therapeutics (BDTX) Shares Outstanding (Weighted Average): 2019-2024
Historic Shares Outstanding (Weighted Average) for Black Diamond Therapeutics (BDTX) over the last 6 years, with Dec 2024 value amounting to $56.6 million.
- Black Diamond Therapeutics' Shares Outstanding (Weighted Average) rose 0.65% to $36.2 million in Q4 2021 from the same period last year, while for Sep 2021 it was $36.2 million, marking a year-over-year increase of 0.84%. This contributed to the annual value of $56.6 million for FY2024, which is 9.59% up from last year.
- As of FY2024, Black Diamond Therapeutics' Shares Outstanding (Weighted Average) stood at $56.6 million, which was up 9.59% from $51.6 million recorded in FY2023.
- In the past 5 years, Black Diamond Therapeutics' Shares Outstanding (Weighted Average) registered a high of $56.6 million during FY2024, and its lowest value of $36.0 million during FY2020.
- Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $51.6 million (2023), whereas its average is $48.2 million.
- Data for Black Diamond Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY spiked of 41.99% (in 2023) over the last 5 years.
- Black Diamond Therapeutics' Shares Outstanding (Weighted Average) (Yearly) stood at $36.0 million in 2020, then rose by 0.65% to $36.2 million in 2021, then increased by 0.38% to $36.4 million in 2022, then spiked by 41.99% to $51.6 million in 2023, then grew by 9.59% to $56.6 million in 2024.